A critical assessment on the role of sentinel node mapping in endometrial cancer.
Endometrial cancer is the most common gynecologic malignancy in the developed countries. Although the high incidence of this occurrence no consensus, about the role of retroperitoneal staging, still exists. Growing evidence support the safety and efficacy of sentinel lymph node mapping. This technique is emerging as a new standard for endometrial cancer staging procedures. In the present paper, we discuss the role of sentinel lymph node mapping in endometrial cancer, highlighting the most controversies features.
Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy. giorgio.bogani@istitutotumori.mi.it.
Giorgio
G
Bogani
Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
Antonino
A
Ditto
Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
Fabio
F
Martinelli
Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
Mauro
M
Signorelli
Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
Stefania
S
Perotto
Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
Domenica
D
Lorusso
Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
Francesco
F
Raspagliesi
D016889:Endometrial Neoplasms / Q000473:pathology* / Q000601:surgery; D005260:Female; D006801:Humans; D015907:Hysteroscopy / Q000379:methods; D015552:Injections, Intralesional; D008197:Lymph Node Excision / Q000379:methods*; D008207:Lymphatic Metastasis; D021701:Sentinel Lymph Node Biopsy / Q000379:methods
Endometrial Neoplasms; Hysteroscopic Injection; Lymph Node Excision; Sentinel Node